Ranbaxy appoints Dr Himadri Sen as President (R

Gurgaon, Mar 11 (UNI) Pharma major Ranbaxy Laboratories Ltd today announced appoint ment of Dr Himadri Sen as its new President - R&D (Generics and NDDS).

Ranbaxy, Chief Executive Officer Malvinder Singh said,'' Dr Sen's appointment adds significant weight to the substantial research and development effort currently underway at Ranbaxy.'' Dr Sen has worked with leading Indian and global pharmaceutical companies in the areas of pharmaceutical research, technology development and transfer, plant support activities and regulatory affairs.

He has been associated in various capacities with organisations like the Manchester Area Health Authority, UK, the St Mary's Hospital and International Development Laboratories, UK, Imperial Chemical Industries, UK, E R Squibb and Sons Ltd, UK, and Lupin and Ranbaxy Labs.

UNI